Fr

equen
tl
yAs
ked
Ques
ti
ons
onVa
cci
nes
(
Eng
li
sh)
F
requ
ent
l
yAs
kedQu
est
i
onsonVa
cci
nes
Gener
alKnowl
edgeonVacci
nes
1.
Howdov
acc
inespr
eventdi
seas
e?
Vacci
nesmi micthevi
rusorbac t
eri
at hatcaus
esdiseas
e
andtr
igger
sthebody’
screati
onofanti
bodies.
Theseanti
bodieswil
lprovi
deprotec
t i
ononc eapers
oni s
i
nfec
tedwiththeact
ualdis
ease-
causingvir
usorbac
teri
a.

2.
Howdov
acc
inesdi
ff
er?
Vacci
nesdi f
feri
nt hei
rc ompos i
ti
onandhowt heytr
iggert
he
i
mmuner esponset oc reateanti
bodies.Theseant i
bodi
es
pr
otectthe body f rom mi cr
oorganisms and s er
ve as
pr
otect
ion onc e a per s on getsinfected wit
h disease.
Vacci
nesc anbeinac t
ivated,weakenedor ki
ll
edcopi
esofthe
wholeorpartofthev ir
usorbac teri
a,orgeneti
cproduct(l
i
ke
mRNAv acc i
nes)thatc r
eat espr
otei
nc opieswit
houtcausi
ng
di
sease.

3.
Whatar
ethepos
sibl
esi
deef
fec
tsofv
acc
inat
ion?
Thepos si
bles i
deef f
ect
sofav acc i
neincl
udepain, r
edness,
i
tchinessors well
ingattheinj
ec t
ions i
te(whichmayl asta
fewhour s
);fever
;feeli
ngofweak nes sorfat
igue;headache;
diz
ziness; diarr
hea; or naus ea. Cons ul
tt he near est
healthc
areprofessional
ify
ouex perienceanyofthese.

4.
Isv
acc
inat
ionmandat
ory
?
No,vacc
inat
ionisnotmandat
ory.
Butthegov
ernmenthi
ghl
y
encour
agesthepublictogetvacci
nat
edandbepr ot
ect
ed
agai
nstprev
entabl
ediseas
e.

beapartofthe
BI
DA
BAKUNATI
ON!
F
requ
ent
l
yAs
kedQu
est
i
onsonVa
cci
nes
Gener
alKnowl
edgeonVacci
nes

5.
Whydoweneedt
ogetv
acc
inat
edf
orCOVI
D-19?
WiththeBI DAstepsandobser
vanceofmini
mum publ
i
c
heal
ths tandar
ds,vacci
nati
on i
s an i
mport
antway t
o
prot
ectyoursel
ffr
om get
ti
ngsever
eCOVID-
19.

6.
Whenwi
l
ltheCOVI
D-19v
acc
inebeav
ail
abl
e?
Thegovernmentiscur
rentl
yintheadvancedstagesof
negot
iat
ions wi
thvari
ous vacci
ne manufac
turers
.We
expectt
hefi
rstv
acci
nes uppl
ytoarr
iv
einthefi
rstquar
ter
of2021.

7.
Whati
sanEmer
genc
yUs
eAut
hor
izat
ion(
EUA)
?
I
ti s an aut hori
zati
on gr ant
ed t hrough a r i
sk-
based
procedureforassessi
ngunr egi
stered(underdevel
opment)
vaccinesordr ugsduringpubl i
cheal t
hemer genciesof
i
nternati
onalconcern.I
taimst oex pedit
eavail
abil
it
yofthe
vaccine ordr ug t
o peopl e affected by publi
c heal
th
emer gencybas ed on es
s enti
als etofav ail
ablequali
ty
,
safet
yandef fi
cacyperfor
manc edat a..

8.
Whowi
l
lgett
hev
acc
inesf
ir
st?
Frontl
ine heal
th worker
s,s eni
or c i
ti
zens
,indi
gent
populati
on,and uni
for
med personnelarethe pr
ior
it
y
groupstobevacci
nat
ed.

beapartofthe
BI
DA
BAKUNATI
ON!
F
requ
ent
l
yAs
kedQu
est
i
onsonVa
cci
nes
COVI
D-19Vacci
nat
ion

9.
Whywi
l
lthepr
ior
it
izedgr
oupsgett
hev
acc
inef
ir
st?
Witht heinit
iall
i
miteds upply,
front
li
nehealthworkersand
uni
for medper sonnelareprior
iti
zedsi
nc et
he yhavehigher
ri
skofex posurewhi l
eon dut yand to all
ow them t o
continuefulfi
ll
i
ngtheirduti
esinbot ht
hepubl i
candprivate
sectors.Vulnerabl
egr oupss uchast heelderl
yandt he
i
ndigentpopul ati
on,arepriori
tiz
edguidedbyt hepri
nc i
ple
ofequi t
y.

10.Can Ipurchas
ethev
acc
inef
rom pr
ivat
e
cl
ini
csorphar
mac i
es?
No, y
ouc annotpurchaseCOVID- 19vacc i
nesfr
om pri
vate
cli
nicsorpharmac i
es.Atpresent,onl
yt hegovernmentis
dulyauthori
zedtoprocureandadmi ni
stervacci
nes.Unti
la
ful
lmar ketauthor
izat
ionisissuedbyt hePhili
ppineFDA,
anyCOVI D-19vacci
nes houl
dnotbes oldt ot
hepublic
.

11.
Ist
hev
acc
inef
reef
orpr
ior
it
ygr
oups
?
Thecostofvacci
nesforpr
ior
it
ygr
oupswi
l
lbes
houl
der
ed
bythePhi
li
ppinegover
nment.

12.I
fIam notpar
tofthepri
ori
tygr
oup,
howwil
lIgetac
cesst
othevacci
ne?
The gover
nmentisc ont
inui
ng negoti
ati
ons t
o ensur
e
adequat
ev acc
ines
upplyforal
lFil
i
pinos,i
ncl
udingthos
e
noti
ntheprior
it
ygr
oups.

beapartofthe
BI
DA
BAKUNATI
ON!
F
requ
ent
l
yAs
kedQu
est
i
onsonVa
cci
nes
COVI
D-19Vacci
nat
ion

13.
Aret
heCOVI
D-19v
acc
iness
afeandef
fec
tiv
e?
COVID-
19v ac
c i
nesthatar
egrantedwi
thEUAbytheFDAar
e
consi
dered safe and ef
fec
tiv
e based on t
he avai
l
abl
e
evi
dencetodate.

14.Aret
herer
isksforcompl
i
cat
ionswhengi
ven
theCOVI
D-19v
ac c
ine?
Yes,l
ikeal
lothervaccines,t
herearer i
sksofc ompli
cat
ions
BUT SEVERE OR LI FE-THREATENING REACTI ONS ARE
EXTREMELYRARE.Thebenef itofprotecti
onagainstse
vere
COVID-19isgreat
erthant herisk.Anyonewhowi l
lgetthe
vacci
newillbeproperl
ye val
uatedandc losel
ymonitor
edby
heal
thprof
essi
onalstofurt
hermi ni
mizeanyris
k.

15.
Whatc
anwedowhi
l
ewai
ti
ngf
ort
hev
acc
ine?

Weur gethepubl ict obemor ev i

gil
antwiththei nf
ormat i
on
foundonl i
ne.Letusmak eitahabittofac tc
hec kandv erif
y
withreli
ables our
ces( DOHFac ebookpage,DOHwebs i
te,
WHO
webs i
te,PIA webs ite)regar
dingnew information.Continue
observ i
ngt hemi nimum publ i
chealths t
andardst oprevent
furt
hert r
ans missi
onoft hevi
rus.

beapartofthe
BI
DA
BAKUNATI
ON!